Barts Health NHS Trust has admitted that a total of 136 operations and hundreds of chemotherapy appointments were cancelled as a result of an IT failure that left a number of critical applications - including imaging services - unavailable to staff.
The failure began on Thursday April 20 and has still not entirely been fixed. But the organisation has said in a statement that its pathology and image viewing applications have been restored across the Trust.
It added that there were a number of other areas where it would "take time" before it's on track again but did not specify which areas these were or what needed to be done.
In a statement sent to Computing, the Trust said: "Unfortunately, it has been necessary to cancel 136 operations, representing about 2.5 per cent of our usual weekly in-patient activity. Several hundred chemotherapy appointments have been cancelled, however we have now recovered the chemotherapy prescribing database."
It added: "Clinical teams have completed a patient-by-patient review to ensure that the appropriate course of action is taken for each of them, endeavouring to keep the disruption to an absolute minimum. We apologise to those affected and will reschedule their appointment for as soon as we are able."
The latest statement is in contrast to the initial statement the Trust sent to Computing last week. Nearly eight days after the IT failure, the organisation said that it had been necessary to "cancel a very small number of elective operations that were reliant on images" - and that "some patients attending outpatients are experiencing delays".
But this has now spiralled into "several hundreds" of chemotherapy appointments and 136 operations having to be cancelled.
The Trust did not reveal exactly how the IT failure occurred but said that it would "work urgently to maintain the operational resilience of its services, using tried and tested contingency plans to keep our patients safe".
Latest Tesla news: Tesla stock price tanks amid reports of 'widening probe' by SEC and claims the base Model 3 loses money
SEC 'probe' takes its toll on Tesla as new research suggests that Tesla loses $6,000 on every $35,000 Model 3
10nm Cannon Lake Core i3-8121U CPUs make a rare outing with Intel's NUC mini PC
'Notorious' Australian child hacker thought he had executed 'flawless' hack
The former employee says that Tesla fired him for bringing the accusations to management internally